Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor.
- Author:
Eunjung YIM
1
;
Ho Jung AN
;
Uiju CHO
;
Youngwoo KIM
;
Seung Hoon KIM
;
Yeon Geun CHOI
;
Byoung Yong SHIM
Author Information
- Publication Type:Letter
- Keywords: Gastrointestinal stromal tumors; KIT mutation; Imatinib mesylate
- MeSH: Gastrointestinal Stromal Tumors*; Imatinib Mesylate*
- From:The Korean Journal of Internal Medicine 2018;33(2):432-434
- CountryRepublic of Korea
- Language:English
- Abstract: No abstract available.
